Authors: KON OM SIHRA BS COMPTON CH LEONARD TB KAY AB BARNES NC

Citation: Om. Kon et al., RANDOMIZED, DOSE-RANGING, PLACEBO-CONTROLLED STUDY OF CHIMERIC ANTIBODY TO CD4 (KELIXIMAB) IN CHRONIC SEVERE ASTHMA, Lancet, 352(9134), 1998, pp. 1109-1113

Authors: KON OM SIHRA BS BARKANS J COMPTON CH BARNES NC KAY AB

Citation: Om. Kon et al., IN-VIVO EFFECTS OF A PRIMATIZED(R) ANTI-CD4 MONOCLONAL-ANTIBODY, SB210396 (IDEC CE9.1), ON CD4-LYMPHOCYTES IN CHRONIC SEVERE ASTHMA( T), Journal of allergy and clinical immunology, 101(1), 1998, pp. 37-37

Authors: LOH LC KON OM SIHRA BS TILL SJ BARKANS J COMPTON CH BARNES NC KAY AB

Citation: Lc. Loh et al., IN-VITRO INHIBITORY EFFECTS OF A PRIMATIZED(R) ANTI-CD4 MONOCLONAL-ANTIBODY, SB210396 (IDEC CE9.1), ON ALLERGEN-SPECIFIC T-CELL PROLIFERATION AND CYTOKINE PRODUCTION IN ATOPIC ASTHMATICS, Journal of allergy and clinical immunology, 101(1), 1998, pp. 46-46

Authors: OSHAUGHNESSY TC GEORGIOU P HOWLAND K DENNIS M COMPTON CH BARNES NC

Citation: Tc. Oshaughnessy et al., EFFECT OF PRANLUKAST, AN ORAL LEUKOTRIENE RECEPTOR ANTAGONIST, ON LEUKOTRIENE D-4 (LTD4) CHALLENGE IN NORMAL VOLUNTEERS, Thorax, 52(6), 1997, pp. 519-522